The Centers for Disease Control and Prevention on Monday said it endorsed its advisory committee’s “recommendation for use of the Pfizer-BioNTech’s licensed vaccine for people 16 and older,” despite statements by the U.S. Food and Drug Administration that the Pfizer-BioNTech vaccine is still authorized only for emergency use.

An advisory panel to the Centers for Disease Control and Prevention (CDC) on Monday unanimously endorsed the U.S. Food and Drug Administration’s (FDA) full approval of the Pfizer and BioNTech COVID vaccine for people 16 years and older, and the CDC immediately adopted the committee’s recommendation.

The endorsement by the CDC’s Advisory Committee on Immunization Practices (ACIP) came after the FDA last week granted full approval to Pfizer’s “mRNA vaccine, which is being marketed as Comirnaty,” CNBC reported.

Following the advisory committee’s endorsement, the CDC issued a statement, in which the agency said:

“Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for use of the Pfizer-BioNTech’s licensed vaccine for people 16 and older.

Read More: DC Endorses FDA Approval of Pfizer COVID Vaccine for 16 and Older

Perc





Source link